Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Oracle buys eClinical specialist Phase Forward for $685m

April 20, 2010 Research and Development Covance, Oracle, Phase Forward

Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …
News

Trial boost for Merck KGaA’s cladribine

April 19, 2010 Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …
News

MedImmune: building a biologics future

April 19, 2010 Research and Development MedImmune, biologics

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …
Feature

Action Pharma appoints new chief executive

April 19, 2010 Research and Development Action Pharma, appointment, research and development

Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …
Appointment

Lixisenatide scores in phase III trial

April 15, 2010 Research and Development GLP-1, Lixisenatide, diabetes

Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. The …
News

Roche buys insulin patch company

April 13, 2010 Research and Development Diagnostics, Roche, diabetes

Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market.  Medingo, formerly a …
News
AquapharmSimonBest

Dr Simon Best joins Aquapharm as chief executive

April 13, 2010 Research and Development Aquapharm, Aquapharm Biodiscovery, appointment, research and development

Aquapharm has appointed Dr Simon Best (pictured) chief executive in a move that sees the Scottish marine biotechnology company’s current …
Appointment

Parexel launches software for post-approval trials

April 12, 2010 Research and Development CRO, Parexel

Contract research organisation Parexel has launched a new web-based technology platform for late phase clinical research that it says makes …
News

Contract research news in brief

April 12, 2010 Research and Development Ingenix, Medpace, NIB, NexMed, RDNIB

A round-up of recent developments in the clinical research arena includes an expansion for NexMed’s pre-clinical division, acquisitions for Medpace …
News

Italy’s new R&D centre launched by Burns

April 9, 2010 Research and Development Italy

The recently retired head of Roche’s pharma division has called for more public-private partnerships in the pharma industry. William Burns …
News

Sanofi-Aventis signs drug with potential to reverse diabetes

April 9, 2010 Research and Development Sanofi, diabetes

Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …
News

ICON and Tigermed forge China alliance

April 7, 2010 Research and Development CRO, China, ICON

Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …
News
RochePitzer

Frank Pitzer made chief executive at NimbleGen

April 7, 2010 Research and Development NimbleGen, Roche, appointment, research and development

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …
Appointment

Talking Point: Responding to Trial Emergencies

April 6, 2010 Research and Development

Unblinding is only done when it is deemed essential for the patients by the subject’s physician or a regulatory body, …
Feature
Thought Leadership
retacrit

Biosimilars: the great balancing act

April 6, 2010 Research and Development biogenerics, biosimilars

Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …
Feature
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026